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a b s t r a c t
Optical coherence tomography (OCT) has recently been demonstrated to measure the ﬁlm coating
thickness of pharmaceutical tablets and pellets directly. The results enable the analysis of inter- and
intra-tablet coating variability at an off-line and in-line setting. To date, only a few coating formulations
have been tried and there is very little information on the applicability of OCT to other coatings. As it is
well documented that optical methods including OCT are prone to scattering leading to limited pene-
tration, some pharmaceutical coatings may not be measurable altogether. This study presents OCT
measurements of 22 different common coatings for the assessment of OCT applicability.
© 2017 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association®. This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Introduction
Film coatings serve the very purpose of achieving color unifor-
mity, light protection, and taste masking. Coatings are additionally
used to modify the drug release or to incorporate an active phar-
maceutical ingredient in the formulation. Coating quality can be
studied either by numerical modeling1 or by the aid of process
analyzers. Various process analytical technology approaches have
been demonstrated for characterizing pharmaceutical coating,
which include near-infrared and Raman spectroscopy,2-4 nuclear
magnetic resonance imaging,5 terahertz pulsed imaging (TPI),6-8
and optical coherence tomography (OCT).9-15 Among these
methods, TPI and OCT are attractive because they offer a direct,
calibration-free coating thickness measurement, where the only
unknown is the coating refractive index that can be obtained as a
one-off measurement with terahertz time-domain spectroscopy
and spectroscopic ellipsometry, respectively. Comparing the two,
TPI has limited resolution (i.e., a lateral spatial of 200 mm and axial
[depth] resolution of 2 mm for coating thickness greater than
30-40 mm) and requires relatively long measurement times (in the
range of 8 ms). OCT, in contrast, can achieve sub-mm resolutions for
coating thickness greater than 10 mm and exploits an ms acquisition
time leading to information on both inter-tablet and intra-tablet
coating variation. Speciﬁcally, OCT has been demonstrated in an
off-line9-11 and in-line setting for characterizing pellets12,13 and
tablets.14,15 However, OCT has limited penetration depth than TPI,
and in some cases fails to image through coatings altogether. This
limitation originates from a similar refractive index between the
tablet core and coating leading to weaker reﬂections, and/or pro-
nounced scattering encountered as the optical beam penetrates
into the sample, resulting in substantial signal attenuation. These
effects ultimately limit the resolvable coating thickness. There is
currently very little information available in the literature on what
coating materials can or cannot be imaged using OCT technology.
This study therefore aims to examine the transparency of a range of
coating formulations for OCT measurement at 840 nm.
Materials and Methods
Tablet Production
The samples used in the present work comprise 22 randomly
selected tablets from 22 different batches where a different
coating formulation was used for each of the batches. The coating
product name, the corresponding alias, and photographs of the
tablets are shown in Table 1. Coating materials were applied to
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bi-convex-shaped tablet cores that contained 50% lactose mono-
hydrate and 50% microcrystalline cellulose. Film coating was per-
formed with a 1500 fully perforated Labcoat IIX (O’Hara
Technologies Inc., Richmond Hill, ON) equipped with one spray
nozzle (Model 970; Düsen-Schlick GmbH, Untersiemau, Germany).
The coating pan has a diameter of 380 mm and a full volume of
4.5 L enabling a batch size of 500 g. Average thickness, diameter,
and weight of the tablet cores (n ¼ 6) were 4.079 ± 0.018 mm,
10.069 ± 0.005 mm, and 321 ± 3 mg, respectively. For measure-
ment comparisons, one side of the tablets was marked by a scratch
mark to serve as a datum. Film coating thickness was estimated by
measuring the physical dimensions of coated tablets with a
micrometer gauge and subtracting it away from the average core
thickness, assuming no dimensional changes to the cores in the
coating process.
Spectral Domain Optical Coherence Tomographic Measurements
An in-house ﬁber-based spectral domain OCT system16 was
developed for B-scan measurements of the coated tablets. As
shown in Figure 1, a superluminescent diode (EXALOS AG,
Schlieren, Switzerland) centered at a wavelength of 840 nm with a
full width at half maximum bandwidth of 55 nm was used as the
light source. The light source provided a theoretical axial resolu-
tion of 5.7 mm in air. The collimated light beam was ﬁrst coupled
into the input port of a 2  2 wideband single mode ﬁber coupler
using a collimator. The light beam was subsequently split (50:50)
into a reference and a probe beam. The reference beam was
collimated by an adjustable collimator (CFC-2X-B; Thorlabs Inc.,
Newton, NJ) and reﬂected by a reference mirror. The probe beam
was focused onto the tablet surface by another identical adjustable
collimator. The focal length was 7 mm, which lead to a lateral
resolution of 20 mm and a depth of ﬁeld of 734 mm. The back-
scattered probe beam interfered with the reﬂected reference
beam at the output port of the ﬁber coupler. The interferogram
was collected by a high resolution spectrometer (Wasatch Pho-
tonics Inc., Logan, UT) consisting of 2048 pixels linear array CCD
camera. In order to obtain a B-scan (cross-sectional image) across
the tablet surface, a translation stage was used to move the tablet
sample at a velocity of 1 mm/s by a motorized stage. The spec-
trometer was set to acquire a spectrum every 6 ms with an
exposure time of 90 ms. In total, 1000 A-scans, which covered a
length of 6 mm with an equivalent step size of 6 mm, were ac-
quired for each tablet to generate a B-scan. The measured optical
spot size on the tablet surface was approximately 20 mm. Mea-
surements were performed perpendicular to the overall tablet
surface plane at the tablet center as opposed to being perpen-
dicular to the tablets’ curved surface.6,7 As such, only the coating
thickness at the tablet central region can be accurately measured
unless the tablet curvature is accounted for.17 The coating thick-
ness is proportional to the separation between adjacent reﬂection
peaks in an A-scan and is determined using d ¼ Dtc/(2n), where
d is the coating thickness, c the speed of light, Dt the peak sepa-
ration, and n the coating refractive index.
Table 1
Images of the Tablets Coated With the Respective Coating Product and the Corresponding Alias
Coating Product ID Product ID Product ID
Coating 1 03F190003 (opadry) Coating 9 03F220071 Coating 17 114F210058
Coating 2 20A29015 (opadry) Coating 10 33G200004 Coating 18 114F250049
Coating 3 31F29070 (opadry II) Coating 11 03B205020 (opadry) Coating 19 200F220052
Coating 4 45F29058 (opadry II) Coating 12 03F205017 Coating 20 493Z240008
Coating 5 02A240002 (opadry) Coating 13 85F205105 Coating 21 TC-117-205006
Coating 6 02B220014 Coating 14 85G200008 Coating 22 TC-116-205001
Coating 7 85F190000 (opadry II) Coating 15 88A210007 (opadry amb II)
Coating 8 70W29079 (opadry ns-g) Coating 16 112A210011
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X-Ray Computed Microtomography
X-ray computed microtomography (XmCT) measurement was
performed on a SkyScan 1172 (control software: Skyscan1172 XmCT
Control Program v1.5; Bruker, Kontich, Belgium). Reconstruction
was performed using the program NRecon (Bruker, v1.6.9.8) on a
single PC using graphical processing unit accelerated reconstruc-
tion (Windows 7 64-bit workstation, 2 Intel Xeon X5647 with 4
cores each, 48 GB RAM, NVIDIA Quadro 4000 with 256 cores)
yielding 3-dimensional datawith an isotropic voxel size of 0.95 mm.
The data acquisition time was 4 h and the image reconstruction
took 0.5 h size for 433 slices of 1116  1116 pixels.
Results and Discussions
Figure 2 shows the acquired B-scans of the 22 coated tablets.
Evidently, the coating-core interface for coatings 1, 2, 7, 8,13, and 18
can be visibly observed. The level of contrast between the air-
coating and coating-core interface in coatings 1, 4, and 13 may be
enhanced with signal denoising.16 It should be noted that in order
to quantify the absolute coating thickness, a clear observation of the
coating-core interface and knowledge of the coating refractive in-
dex is required.16,17 As refractive index remains unknown in this
study, coating thickness is not determined but instead, estimated
using a micrometer gauge. As a quick check, wemeasured coating 9
using XmCT, sub-volume shown in Supplementary Figure S1, that
yielded a thickness of 51.0 ± 6.2 mm (n ¼ 10) in agreement with the
estimated thickness of 59 ± 10 mm. No thickness information could
be derived with OCT in this instance due to an absence of the
coating-core interface. Closer inspection of Supplementary
Figure S1 also shows that some of the coating has fused into the
tablet core,18,19which would have caused a gradual refractive index
change leading to low contrast in OCT measurement. To better
isolate the causes behind OCT opaqueness at 840 nm, the coating
compositions for the respective coatings are listed in Table 2. In
coating compositions without pigments or colorants, generally the
coating-core interface in B-scans is visible. Coatings 1 and 3,
however, are notable exceptions because of the additional lactose
and polydextrose, which may have increased scattering and
reduced the refractive index contrast between the core and coating
as the core also contained 50% lactose monohydrate. This would
then reduce the reﬂected signal intensity from the coating-core
interface, resulting in no clear observation of the coating-core
interface on the B-scan. Assuming negligible optical absorption in
the polymer binder,20 for compositions containing pigments, in
particular, titanium dioxide, the coating-core interface is not visible
at all. This is due to the pigment particle size and a relatively high
value of the effective refractive index that in turn increases
reﬂection at the air-coating interface, meaning that only a fraction
of incidence beam can actually penetrate into the coating.20 As the
remaining beam travels into the coating, more scattering is
encountered leading to a further signal reduction for measurement.
The scattering effect for yellow iron oxide compared to titanium
dioxide is generally weaker at near-infrared wavelengths.21 Despite
this, coating 9 is still opaque to OCT because of the gradual
refractive index change encountered because the coating disper-
sion has diffused into the core material.18,19 On the contrary, 3%
weight gain red coating (coating 18) is transparent to OCT largely
due to a comparatively larger difference between the coating and
core refractive index in spite of the increased air-coating reﬂection
from the similar colored coating to the incident beam.22 For another
red coating (coating 20), the coating-core interface is not visible
Figure 1. Schematic of an in-house spectral domain OCT system with a tablet placed in the perforated coating pan. C1 and C2, adjustable collimators; L1, L2, and L3, lens;
BS, beam-splitter; SLD, superluminescent diode.
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due to the titanium dioxide used in a comparatively thicker coating
(10% weight gain). Finally, it is interesting to note that where the
coating contains only talc and dye in the colorant as in the case of
coating 13, the coating-core interface is marginally visible in the
OCT measurements.
Conclusion
With the emergence of OCT for the non-destructive evaluation
of pharmaceutical coatings, it is important to know the limitations
of the technique. We have presented OCT measurements for a
range of pigments and formulations based on a popular immediate
release coating platform used in the pharmaceutical industry today.
Our ﬁndings show that coating transparency for OCT measurement
ultimately depends on the pigment type, coating formulation, and
the tablet core as well as the coating process itself. Our ﬁndings
further show that where the coating material contains titanium
dioxide, either alone or together with other pigments, OCT mea-
surement becomes adversely affected by scattering resulting in a
blurred coating-core interface that makes coating thickness quan-
tiﬁcation impossible. For coatings without titanium dioxide,
coating transparency is not always guaranteed. In order to precisely
explain ourmeasurements, mechanisticmodeling could be applied.
We therefore envision that OCT might be best suited for process
Figure 2. B-scans of the coated tablets where the air-coating interface can be observed and the coating-core interface is only visible for only coatings 1, 2, 7, 8, 13, and 18.
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Table 2
Coating Compositions of the Coating Aliases With the Highlighted Rows Corresponding to OCT Transparency
Coating Nominal Weight Gain Measured Weight Gain (%) Estimated Coating Thickness (mm) Polymer Plasticizer Colorants Auxiliary
Pigment Dye
Coating 1 3% 5.1 ± 1.1 40 ± 3 HPMC PEG
Coating 2 3% 5.5 ± 1.1 54 ± 5 HPMC
HPC
Coating 3 3% 6.2 ± 1.1 46 ± 4 HPMC PEG Lactose
Coating 4 3% 6.0 ± 1.1 50 ± 3 HPMC Propylene glycol Polydextrose
Coating 5 3% 3.4 ± 1.1 47 ± 9 HPMC Red iron oxide
Yellow iron oxide
Titanium dioxide
Talc
Coating 6 3% 2.1 ± 1.2 27 ± 13 HPMC PEG Yellow iron oxide
Titanium dioxide
Coating 7 3% 5.1 ± 1.2 37 ± 4 PVA PEG Talc
Coating 8 3% 5.7 ± 1.1 41 ± 3 Sodium CMC Tapioca dextrin Lecithin
Sodium citrate
Dextrose
Coating 9 3% 3.6 ± 1.1 59 ± 10 HPMC PEG Yellow iron oxide
Coating 10 3% 3.2 ± 1.4 50 ± 18 HPMC PEG
Triacetin
Yellow iron oxide
Black oxide
Titanium dioxide
Lactose
Coating 11 3% 3.4 ± 1.0 53 ± 9 HPMC PEG Titanium dioxide Blue Capmul
Coating 12 3% 3.5 ± 1.1 55 ± 11 HPMC PEG Titanium dioxide
Talc
Blue
Coating 13 3% 3.1 ± 1.1 52 ± 10 PVA PEG Talc Blue
Coating 14 3% 3.4 ± 1.3 47 ± 12 PVA PEG Black oxide
Carmine
Titanium dioxide
Talc
Blue Lecithin
Coating 15 4% 4.3 ± 1.1 52 ± 12 PVA Titanium dioxide
Talc
Cu-chlorophyllin SLS
Coating 16 4% 5.0 ± 1.1 59 ± 10 HPMC
HPC
Titanium dioxide
Talc
Cu-chlorophyllin
Coating 17 3% 3.3 ± 1.2 60 ± 14 PVA PEG Riboﬂavine
Spirilina
Veg carbon black
Titanium dioxide
Talc
Coating 18 3% 2.2 ± 1.1 28 ± 12 PVA PEG Yellow iron oxide
Carmine
Talc
Polysorbate
Coating 19 4% 6.4 ± 1.4 70 ± 15 PVA
Eudragit
PEG Yellow iron oxide
Titanium dioxide
Talc
Blue
Yellow
Coating 20 10% 9.9 ± 1.6 105 ± 13 Eudragit Carmine
Titanium dioxide
Talc
Poloxamer
SLS
Sodium bicarbonate
Calcium silicate
Coating 21 3% 3.4 ± 1.1 48 ± 10 PVA PEG Titanium dioxide
Talc
Blue
Yellow
Lecithin
Coating 22 3% 3.8 ± 1.2 54 ± 12 HPMC Propylene glycol Titanium dioxide Blue
The weight and tablet thickness were measured of 6 tablets per batch. The coating thickness and weight gain were calculated from the average weight and tablet thickness measurements of each batch and the tablet core.
The standard deviation was calculated by applying the error propagation law.
HPMC, hydroxypropyl methylcellulose; PEG, polyethylene glycol; PVA, poly(vinyl alcohol); CMC, carboxymethyl cellulose; SLS, sodium lauryl sulfate; HPC, hydroxypropyl cellulose.
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analytical technology applications of functional polymeric coatings,
and in particular for multiparticulates where high pigmentations
can be avoided.10-15,23 For coatings on tablets where pigments
cannot be avoided, TPI is a proven alternative for coating thickness
greater than 30-40 mm.6,24
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